Approved by the Board on: 23 April 2024
Based on the recommendation of the Strategy Committee, the Board:
Additionally, while the Board expects efforts will be made to fully implement the Policy upon its approval, the Board understands that for implementation of certain aspects of the Policy a reasonable transition period may be needed. The Board authorizes the Secretariat to allow for such a transition period when needed.
There are no budgetary implications.
The Expert Review Panel (“ERP”) is funded through the NextGen Market Shaping Strategic Initiative. The Global Fund will work closely with WHO to prioritize products for assessment using the ERP.